-The Hindu It is not the responsibility of the government alone to act in order to curb corruption; corporate firms need to be proactive as well in checking fraudulent financial practices The winter session of Parliament witnessed a noisy debate on the black money controversy. Governments of all hues have disappointed the Indian janata on the issue of black money and the failure is often associated with a perceived nexus between politicians...

-Business Standard Domestic regulators need to be stricter about quality violations to protect both Indian pharma exports as well as the country's image Even as major Indian drug companies continue to make news for impurities in the medicines they make and faulty - or if the USFDA is to be believed, falsified - data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent...

-The Hindu Consent does not matter, says study A majority of parents who get their children married before the legal age do not even seek their consent, and among those who do, the child not consenting does not stop the marriage, new data has shown. In 2011, the Planning Commission selected the G.B. Pant Institute of Studies in Rural Development, Lucknow, for a study on child marriage in India. The 2005-06 National Family...

-The Telegraph New Delhi: A government panel that evaluated Muslims' post-Sachar socio-economic conditions has suggested an anti-discrimination law, targeted mainly at employers, to combat the growing disparity between the community and the rest of the country. The committee, headed by Jawaharlal Nehru University professor Amitabh Kundu, has failed to detect any "sea change on the ground" despite several welfare plans being launched for the community after Sachar's late-2006 report. Like Sachar, the Kundu...

-The Telegraph Regulators in several European countries are suspending marketing approval for 25 generic drugs because of concerns over the quality of data from human studies conducted by an Indian contract research company, a French medical safety agency said on Friday. Drug regulators in Belgium, France, Germany and Luxembourg have decided to suspend the marketing authorisation for the generic drugs after they discovered "irregularities" in documents relating to human studies conducted by...